FFA
HRMY icon

Farther Finance Advisors’s Harmony Biosciences HRMY Stock Holding History

Farther Finance Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32K Buy
816
+510
+167% +$19.7K ﹤0.01% 3779
2026
Q2 		$11.1K Sell
306
-28
-8% -$883 ﹤0.01% 4352
2026
Q1 		$9.34K Sell
334
-302
-47% -$9.9K ﹤0.01% 4157
2025
Q4 		$23.8K Buy
636
+618
+3,433% +$20.3K ﹤0.01% 3325
2025
Q3 		$496 Sell
18
-111
-86% -$3.82K ﹤0.01% 4545
2025
Q2 		$4.08K Sell
129
-95
-42% -$3.06K ﹤0.01% 3440
2025
Q1 		$7.26K Buy
224
+218
+3,633% +$7.82K ﹤0.01% 2890
2024
Q4 		$206 Hold
6
– – ﹤0.01% 3654
2024
Q3 		$239 Buy
6
+1
+20% +$35 ﹤0.01% 3609
2024
Q2 		$152 Buy
5
+2
+67% +$60 ﹤0.01% 3537
2024
Q1 		$99 Hold
3
– – ﹤0.01% 3381
2023
Q4 		$97 Sell
3
-7
-70% -$195 ﹤0.01% 3305
2023
Q3 		$328 Buy
+10
New +$347 ﹤0.01% 2363
2023
Q2 		– Sell
-3
Closed -$98 – 2530
2023
Q1 		$98 Hold
3
– – ﹤0.01% 2285
2022
Q4 		$165 Buy
+3
New +$165 ﹤0.01% 2069

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's HRMY Position: Q3 2026 in Review

Farther Finance Advisors increased its Harmony Biosciences (HRMY) stake by 167% in Q3 2026, buying an estimated $19.7K and bringing the position to 816 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #3779.

Farther Finance Advisors first reported a position in HRMY in Q4 2022 and has held it in 15 quarters since. 9 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Farther Finance Advisors held 816 shares of Harmony Biosciences worth $32K as of Q3 2026.
  • Farther Finance Advisors bought 510 Harmony Biosciences shares in Q3 2026, an estimated $19.7K.
  • Harmony Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3779 holding.
  • Farther Finance Advisors first reported a position in Harmony Biosciences in Q4 2022 and has held it in 15 quarters since.
  • 9 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.